Company profile
Neomorph, Inc.
Advancing the science of targeted protein degradation to destroy ‘undruggable’ proteins and cure disease.
- Industry
- Biotechnology Research
- Employees
- 94
- Headquarters
- San Diego, CA
- Founded
- 2020
- LinkedIn followers
- 9,021
- Office locations
- 1
Neomorph, Inc. company summary
Neomorph, Inc. is a company in the Biotechnology Research industry, headquartered in San Diego, CA, founded in 2020. On LinkedIn the company has around 94 employees and 9,021 followers. Its listed specialties include Targeted Protein Degradation and Molecular Glue Degraders.
What technology does Neomorph, Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Neomorph, Inc.
Neomorph is a clinical-stage biotechnology company pioneering the discovery and development of molecular glue degraders to unlock new therapeutic possibilities across serious diseases. By engineering neomorphic protein surfaces, Neomorph enables precision targeted protein degradation of disease drivers that have historically been considered undruggable. As a leader in molecular glue technology, Neomorph has created the world’s largest proprietary molecular glue target space, spanning multiple novel degrons across an expansive portfolio of E3 ubiquitin ligases. The company was founded in 2020 and is venture-backed by Deerfield Management Company.
Specialties
Where is Neomorph, Inc. located?
Neomorph, Inc. lists 1 location.
Compare companies similar to Neomorph, Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Neomorph, Inc. neomorph.com | Biotechnology Research | 94 | 2020 | San Diego, CA |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Neomorph, Inc.
What does Neomorph, Inc. do?
Neomorph is a clinical-stage biotechnology company pioneering the discovery and development of molecular glue degraders to unlock new therapeutic possibilities across serious diseases. By engineering neomorphic protein surfaces, Neomorph enables precision targeted protein degradation of disease drivers that have historically been considered undruggable. As a leader in molecular glue technology, Neomorph has created the world’s largest proprietary molecular glue target space, spanning multiple novel degrons across an expansive portfolio of E3 ubiquitin ligases. The company was founded in 2020 and is venture-backed by Deerfield Management Company.
How many employees does Neomorph, Inc. have?
Neomorph, Inc. has around 94 employees on LinkedIn.
Where is Neomorph, Inc. headquartered?
Neomorph, Inc. is headquartered in San Diego, CA.
When was Neomorph, Inc. founded?
Neomorph, Inc. was founded in 2020.
Build a lead list from companies like Neomorph, Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.